Lv1
58 积分 2025-08-25 加入
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
4天前
已完结
Targeting CNS Metastases in Non–Small Cell Lung Cancer With Evolving Approaches Using Molecular Markers
5天前
已完结
Response with pembrolizumab in a patient with EGFR mutated non-small cell lung cancer harbouring insertion mutations in V834L and L858R
7天前
已完结
Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations
8天前
已完结
Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer
8天前
已完结
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
8天前
已完结
EGFR V834L and L858R Comutation Is Associated With Response to Osimertinib in Non–Small-Cell Lung Cancer
8天前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
9天前
已完结
OA02.03: Molecular Diagnosis and Management of Leptomeningeal Metastases With Evolving Therapeutic Paradigm in Advanced Lung Cancer: A Contemporary Study
21天前
已关闭
Survival outcomes of upfront versus delayed craniocerebral radiotherapy in EGFR-mutant NSCLC patients treated with third-generation EGFR-TKIs
25天前
已完结
皖公网安备34019202002308
